Velocity Clinical Research, Valparaiso — Valparaiso, Indiana

Velocity Clinical Research, Valparaiso is a clinical research site located in Valparaiso, Indiana, United States 46383.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research, Valparaiso has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Obesity, Type 2 Diabetes, Diabetes Mellitus, Type 2.

Sponsors: Pfizer, Eli Lilly and Company, ModernaTX, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research, Valparaiso?

Velocity Clinical Research, Valparaiso has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research, Valparaiso conducted?

Velocity Clinical Research, Valparaiso has 7 clinical trials on record, with 1 currently active. Their work covers Obesity, Type 2 Diabetes, Diabetes Mellitus, Type 2.

Is Velocity Clinical Research, Valparaiso accredited by Crixeo Health?

Yes — Velocity Clinical Research, Valparaiso holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Velocity Clinical Research, Valparaiso?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.